A new digitized method of the compulsive gnawing test revealed dopaminergic activity of salvinorin A - In vivo

Planta Medica

Volumn 76, Issue 13, 2010, Pages 1405-1410

  Phipps, Stephen M ^a   Butterweck, Veronika ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

compulsive gnawing; dopaminergic activity; Lamiaceae; opioid receptor; Salvia divinorum; salvinorin A

Indexed keywords

AMFEBUTAMONE; APOMORPHINE; HALOPERIDOL; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NOMIFENSINE; NORBINALTORPHIMINE; SALVINORIN A;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG STRUCTURE; GNAWING; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; SALVIA;

ANALOG-DIGITAL CONVERSION; ANIMALS; BEHAVIOR, ANIMAL; COMPULSIVE BEHAVIOR; DISEASE MODELS, ANIMAL; DITERPENES, CLERODANE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MASTICATION; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NARCOTIC ANTAGONISTS; PLANT EXTRACTS; RECEPTORS, OPIOID, KAPPA; SALVIA;

LAMIACEAE; MUS; SALVIA DIVINORUM;

EID: 77956675809     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1240954     Document Type: Article

References (36)

1. Canales J J., Gilmour G, Iversen S D. The role of nigral and thalamic output pathways in the expression of oral stereotypies induced by amphetamine injections into the striatum. Brain Res 2000 856 176-183
2. 5 receptor knockout mice for cocaine locomotor sensitization. Psychopharmacology (Berl) 2008 200 117-127
3. Taha E B., Redgrave P. Neuroleptic suppression of feeding and oral stereotypy following microinjections of carbachol into substantia nigra. Neurosci Lett 1980 20 357-361
4. Ther L, Schramm H. Apomorphine synergism (induced gnawing in mice) as a test for the differentiation of psychotropic substances. Arch Int Pharmacodyn Ther 1962 138 302-310
5. Ernst A M. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia 1967 10 316-323
6. Pedersen V. Potentiation of apomorphine effect (compulsive gnawing behaviour) in mice. Acta Pharmacol Toxicol (Copenh) 1967 25 (Suppl.4) 63
7. De Feo G, Lisciani R, Pavan L, Samarelli M, Valeri P. Possible dopaminergic involvement in biting compulsion induced by large doses of clonidine. Pharmacol Res Commun 1983 15 613-619
8. Hedley L R., Wallach M B. Potentiation of apomorphine-induced gnawing in mice. Prog Neuropsychopharmacol Biol Psychiatry 1983 7 47-56
9. Ernst A M. Compulsive gnawing. Pharmacol Ther 1976 2 173-184
10. Vogel H G. Drug discovery and evaluations: pharmacological assays, 2nd edition. Berlin Springer-Verlag 2002 567
11. Roth B L., Baner K, Westkaemper R, Siebert D, Rice K C., Steinberg S, Ernsberger P, Rothmann R B. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci USA 2002 99 11934-11939
12. 2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse 2009 63 698-704
13. Grundmann O, Phipps S M., Zadezensky I, Butterweck V. Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology. Planta Med 2007 73 1039-1046
14. Butelman E R., Harris T J., Kreek M J. The plant-derived hallucinogen salvinorin A produces kappa-opioid agonist-like discriminative effects in rhesus monkeys. Psychopharmacology (Berl) 2004 172 220-224
15. Willmore-Fordham C B., Krall D M., McCurdy C R., Kinder D H. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats. Neuropharmacology 2007 53 481-486
16. Baker L E., Panos J J., Killinger B A., Peet M M., Bell L M., Haliw L A., Walker S L. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. Psychopharmacology (Berl) 2009 203 203-211
17. Braida D, Capurro V, Zani A, Rubino T, Vigano D, Parolaro D, Sala M. Potential anxiolytic-and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol 2009 157 844-853
18. Tang A H., Code R A. Discriminative stimulus properties of nalorphine in the rhesus monkeys. J Pharmacol Exp Ther 1983 227 563-569
19. Siebert D J. Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol 1994 43 53-56
20. Weber C C., Eckert G P., Mueller W E. Effects of antidepressants on the brain/plasma distribution of corticosterone. Neuropsychopharmacology 2006 31 2443-2448
21. Rojas-Corrales M O., Berrocoso E, Gibert-Rahola J, Mico J A. Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. J Psychopharmacol 2004 18 404-411
22. Redolat R, Vidal J, Gomez M C., Carrasco M C. Effects of acute bupropion administration on locomotor activity in adolescent and adult mice. Behav Pharmacol 2005 16 59-62
23. Mague S D., Pliakas A M., Todtenkopf M S., Tomasiewicz H C., Zhang Y, Stevens W C., Jones R M., Portoghese P S., Carlezon W A. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 2003 305 323-330
24. Sotnikova T D., Beaulieu J M., Barak L S., Wetsel W C., Caron M G., Gainetdinov R R. Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol 2005 3 e271
25. McKerchar T L., Fowler S C. Dissimilar effects of subchronic clozapine and haloperidol on operant lever pressing in C57BL/6J, BALB/cJ, and LP/J mice. Behav Pharmacol 2005 16 585-589
26. McCurdy C R., Sufka K J., Smith G H., Warnick J E., Nieto M J. Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol Biochem Behav 2006 83 109-113
27. Moss D E., McMaster S B., Castaneda E, Johnson R L. An automated method for studying stereotyped gnawing. Psychopharmacology (Berl) 1980 69 267-269
28. Christensen A V., Fjalland B, Nielsen I M. On the supersensitivity of dopamine receptors, induced by neuroleptics. Psychopharmacology (Berl) 1976 48 1-6
29. Zhang Y, Butelman E R., Schlussman S D., Ho A, Kreek M J. Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology (Berl) 2005 179 551-558
30. Thompson A C., Zapata A, Justice Jr J B., Vaughan R A., Sharpe L G., Shippenberg T S. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. J Neurosci 2000 20 9333-9340
31. Gehrke B J., Chefer V I., Shippenberg T S. Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology (Berl) 2008 197 509-517
32. Beerepoot P, Lam V, Luu A, Tsoi B, Siebert D, Szectman H. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole. Neurosci Lett 2008 446 101-104
33. Perreault M L., Graham D, Scattolon S, Wang Y, Szechtman H, Foster J A. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. Psychopharmacology (Berl) 2007 194 485-496
34. Delfs J M., Kelley A E. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neurosci Lett 1990 39 59-67
35. Dadkar N K., Dohadwalla A N., Bhattacharva B K. The involvement of serotoninergic and noradrenergic systems in the compulsive gnawing in mice induced by imipramine and apomorphine. J Pharm Pharmacol 1976 28 68-69
36. Schoffelmeer A N., Hogenboom F, Mulder A H. Kappa1-and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br J Pharmacol 1997 122 520-524